MarketPeel
Insider Trading Intelligence
DW

Deborah Weitzman

CAH
CEO, PSS SEGMENT · CARDINAL HEALTH INC · CIK 0001942639
FILING MIX · LIFETIME39%/61%
BUYS
12
SELLS
19
TOTAL VALUE
$25.22M
COMPANIES
1
ACTIVE SINCE
Dec 2022
HOLDINGS NOW
78,590
AVG SELL PX
$149.87
TRADE KIND
SHOWING 31 / 31
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Deborah Weitzman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%-1.61%+1.09%-2.70%-3.76%
14d3+66.67%-0.42%+1.27%-1.70%-1.35%
30d3+100.00%-3.14%+1.95%-5.09%-6.20%
60d3+33.33%+1.26%+1.99%-0.73%-2.38%
90d3+0.00%+19.18%+6.08%+13.11%+15.83%
180d3+33.33%+19.44%+13.30%+6.13%+4.88%
1y3+0.00%+30.41%+27.69%+2.72%-5.94%
2y3(1 pending)+0.00%+83.08%+51.02%+32.06%+32.06%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CAH · 78,590 shares · as of Aug 18, 2026
028,75457,50786,261115,0142023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 12 buys / 19 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
6,665$235.30$1.57M78,590Aug 18, 2026Aug 20, 2026View →
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
408$236.59$96.5K78,182Aug 18, 2026Aug 20, 2026View →
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
281$237.44$66.7K77,901Aug 18, 2026Aug 20, 2026View →
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
29,759$235.17$7.00M85,255Aug 15, 2026Aug 18, 2026View →
CAH
CARDINAL HEALTH INC
PURCHASEGRANT
Stock grant
7,314115,014Aug 15, 2026Aug 18, 2026View →
CAH
CARDINAL HEALTH INC
PURCHASEGRANT
Stock grant
54,823107,700Aug 4, 2026Aug 4, 2026View →
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
551$212.26$117.0K52,877Dec 1, 2025Dec 2, 2025View →
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
21,367$150.53$3.22M53,428Aug 20, 2025Aug 20, 2025View →
CAH
CARDINAL HEALTH INC
PURCHASEGRANT
Stock grant
10,69498,923Aug 15, 2025Aug 19, 2025View →
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
24,128$150.22$3.62M74,795Aug 15, 2025Aug 19, 2025View →
CAH
CARDINAL HEALTH INC
PURCHASEGRANT
Stock grant
39,10088,229Aug 12, 2025Aug 12, 2025View →
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
632$122.24$77.3K49,129Dec 2, 2024Dec 3, 2024View →
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
2,341$107.91$252.6K49,761Aug 16, 2024Aug 19, 2024View →
CAH
CARDINAL HEALTH INC
PURCHASEGRANT
Stock grant
13,53052,102Aug 15, 2024Aug 19, 2024View →
CAH
CARDINAL HEALTH INC
SALE
CEO, PSS Segment
9,918$106.36$1.05M38,572Aug 15, 2024Aug 19, 2024View →
CAH
CARDINAL HEALTH INC
PURCHASEGRANT
Stock grant
13,92648,490Aug 13, 2024Aug 14, 2024View →
CAH
CARDINAL HEALTH INC
SALE
CEO, Pharmaceutical Segment
638$107.08$68.3K34,564Dec 1, 2023Dec 5, 2023View →
CAH
CARDINAL HEALTH INC
PURCHASE
CEO, Pharmaceutical Segment
6,279$83.19$522.4K56,471Nov 27, 2023Nov 29, 2023View →
CAH
CARDINAL HEALTH INC
SALE
CEO, Pharmaceutical Segment
6,2790Nov 27, 2023Nov 29, 2023View →
CAH
CARDINAL HEALTH INC
PURCHASE
CEO, Pharmaceutical Segment
15,373$66.43$1.02M71,844Nov 27, 2023Nov 29, 2023View →
CAH
CARDINAL HEALTH INC
SALE
CEO, Pharmaceutical Segment
5,9900Nov 27, 2023Nov 29, 2023View →
CAH
CARDINAL HEALTH INC
SALE
CEO, Pharmaceutical Segment
15,3730Nov 27, 2023Nov 29, 2023View →
CAH
CARDINAL HEALTH INC
SALE10b5-1
10b5-1 plan
36,642$106.31$3.90M35,202Nov 27, 2023Nov 29, 2023View →
CAH
CARDINAL HEALTH INC
PURCHASE
CEO, Pharmaceutical Segment
5,990$84.27$504.8K50,192Nov 27, 2023Nov 29, 2023View →
CAH
CARDINAL HEALTH INC
SALE
CEO, Pharmaceutical Segment
6,712$89.81$602.8K44,202Aug 28, 2023Aug 29, 2023View →
CAH
CARDINAL HEALTH INC
PURCHASE
CEO, Pharmaceutical Segment
6,712$71.43$479.4K50,914Aug 28, 2023Aug 29, 2023View →
CAH
CARDINAL HEALTH INC
SALE
CEO, Pharmaceutical Segment
6,7120Aug 28, 2023Aug 29, 2023View →
CAH
CARDINAL HEALTH INC
PURCHASEGRANT
Stock grant
15,48744,202Aug 16, 2023Aug 17, 2023View →
CAH
CARDINAL HEALTH INC
SALE
CEO, Pharmaceutical Segment
10,966$92.99$1.02M28,715Aug 15, 2023Aug 17, 2023View →
CAH
CARDINAL HEALTH INC
PURCHASEGRANT
Stock grant
12,76039,681Aug 7, 2023Aug 8, 2023View →
CAH
CARDINAL HEALTH INC
SALE
CEO, Pharmaceutical Segment
380$80.17$30.5K26,921Dec 1, 2022Dec 5, 2022View →
Other insiders · CAH
Loading peer insiders…
About this filer
CIK 0001942639
ROLE
CEO, PSS Segment
PRIMARY
CAH
COMPANIES
1
ACTIVE SINCE
Dec 2022
MARKETPEEL · /INSIDER/0001942639DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback